منابع مشابه
The immune system in Duchenne muscular dystrophy: Friend or foe
Duchenne muscular dystrophy (DMD) is a genetic disease caused by mutations in the X-linked dystrophin gene, resulting in reduced or absent protein production, subsequently leading to the structural instability of the dystroglycan complex (DGC), muscle degeneration, and early death in males. Thus, current treatments have been targeting the genetic defect either by bypassing the mutation through ...
متن کاملThe immune system in cancer metastasis: friend or foe?
Metastatic disease is the leading cause of death among cancer patients and involves a complex and inefficient process. Every step of the metastatic process can be rate limiting and is influenced by non-malignant host cells interacting with the tumor cell. Over a century ago, experiments first indicated a link between the immune system and metastasis. This phenomenon, called concomitant immunity...
متن کاملImmune System, Friend or Foe of Oncolytic Virotherapy?
Oncolytic viruses (OVs) are an emerging class of targeted anticancer therapies designed to selectively infect, replicate in, and lyse malignant cells without causing harm to normal, healthy tissues. In addition to direct oncolytic activity, OVs have shown dual promise as immunotherapeutic agents. The presence of viral infection and subsequently generated immunogenic tumor cell death trigger inn...
متن کاملErythropoietin: friend and foe!
Our knowledge of the erythropoietin (Epo) molecule has come a long way since Carnot and Deflandre’s landmark observations, over a century ago, attributing the increase in red blood cells to a factor called ‘hemopoietin’. For decades, the scientific community thought that the role of Epo was limited to red blood cell production. However, since the mid 1990s, Epo has been shown to exert numerous ...
متن کاملUSP10: Friend and Foe
The tumor suppressor protein p53, a crucial player in the DNA damage response, is regulated in many ways, most notably through ubiquitination. In this issue, Yuan et al. (2010) identify the deubiquitinating protease USP10 as a new regulator of p53 in the DNA damage response and tumor development.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Clinical Nutrition
سال: 2006
ISSN: 0002-9165,1938-3207
DOI: 10.1093/ajcn/83.2.187